Efficacy of [ 177 Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Mercedes MitjavilaPaula Jimenez-FonsecaPilar BellóVirginia PubulJuan Carlos PercovichAmparo Garcia-BurilloJorge HernandoJavier ArbizuEmilia RodeñoMontserrat EstorchBelén LlanaMaribel CastellónLina García-CañamaquePablo GajateMaria Carmen RiescoMaria Begoña MiguelDavid Balaguer-MuñozAna CustodioJuana María CanoAlexandra RepettoPilar Garcia-AlonsoMaria Angustias MurosJose Luis Vercher-ConejeroAlberto Carmona-BayonasPublished in: European journal of nuclear medicine and molecular imaging (2023)
Lu]Lu-DOTATATE in a wide range of SSTR-expressing NENs, regardless of location, with clinical benefit and superimposable survival outcomes between pNENs and other GEP and NGEP tumor subtypes different from midgut NENs.